Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial

Table 1

Baseline characteristics of patients.

Parameter	Before therapy			After therapy (5 w)
	DAPA+CSII ()	CSII ()	value	DAPA+CSII ()	CSII ()	△DAPA+CSII	△CSII	value
Gender (M/F)	34 (22/12)	32 (26/6)	0.13	/	/	/	/	/
Age (years)			0.15	/	/	/	/	/
Weight (kg)			0.26					<0.01
BMI (kg/m^2)			0.08					<0.01
SBP (mmHg)			0.89					0.90
DBP (mmHg)			0.97					0.09
Na^+ (mmol/L)			0.74					0.14
HbA1c (%)			0.52					0.93
FBG (mmol/L)			0.30					0.08

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HbA_1c: hemoglobin A1c. Data were presented as ; ; . △: before therapy-after therapy (5 w).